Literature DB >> 17028430

Differentiated dopaminergic MN9D cells only partially recapitulate the electrophysiological properties of midbrain dopaminergic neurons.

C E Rick1, A Ebert, T Virag, M C Bohn, D J Surmeier.   

Abstract

The cell line MN9D, a fusion of embryonic ventral mesencephalic and neuroblastoma cells, is extensively used as a model of dopamine (DA) neurons because it expresses tyrosine hydroxylase and synthesizes and releases DA. These cells are also used to test mechanisms and potential therapeutics relevant to the loss of DA neurons in Parkinson's disease. To date, little work has been done to determine whether MN9D cells electrophysiologically resemble mature DA neurons. We examined sodium, calcium and potassium currents in undifferentiated and differentiated MN9D cells, and compared these to those found in acutely dissociated mouse substantia nigra pars compacta DA neurons. It was observed that undifferentiated MN9D cells bore no resemblance to DA neurons. Upon differentiation with butyric acid with or without a prior treatment with glial cell line-derived neurotrophic factor, differentiated MN9D cells produce an electrophysiological profile that more closely resembles substantia nigra pars compacta DA neurons even though the A-type potassium current remains noticeably absent. These observations demonstrate that undifferentiated MN9D cells are not reasonable models of DA neurons. Although differentiated MN9D cells are closer to the mature DA neuronal phenotype, they do not fully mimic DA neurons and are likely to be of questionable value as a model because of their substantive differences, including the lack of the characteristic A-type potassium current. The future use of one or a combination of growth or other factors to differentiate MN9D cells may yield a more useful model system for Parkinson's disease studies in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028430     DOI: 10.1159/000095115

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  13 in total

1.  Translocator protein 18 kDa negatively regulates inflammation in microglia.

Authors:  Keun-Ryung Bae; Hyun-Jung Shim; Deebika Balu; Sang Ryong Kim; Seong-Woon Yu
Journal:  J Neuroimmune Pharmacol       Date:  2014-04-01       Impact factor: 4.147

2.  Expression of synaptophysin protein in different dopaminergic cell lines.

Authors:  Xiang Bai; Randy Strong
Journal:  J Biochem Pharmacol Res       Date:  2014-12

3.  Expression of the μ, κ, and δ-opioid receptors and tyrosine hydroxylase in MN9D cells.

Authors:  Pengxiang Tian; Weibo Shi; Jie Liu; Jie Wang; Chunling Ma; Qian Qi; Bin Cong; Yingmin Li
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Alpha-synuclein mediates alterations in membrane conductance: a potential role for alpha-synuclein oligomers in cell vulnerability.

Authors:  Li Rebekah Feng; Howard J Federoff; Stefano Vicini; Kathleen A Maguire-Zeiss
Journal:  Eur J Neurosci       Date:  2010-06-14       Impact factor: 3.386

5.  Physical and functional interaction between the dopamine transporter and the synaptic vesicle protein synaptogyrin-3.

Authors:  Loreto A Egaña; Rolando A Cuevas; Tracy B Baust; Leonardo A Parra; Rehana K Leak; Sarah Hochendoner; Karina Peña; Marisol Quiroz; Weimin C Hong; Mario M Dorostkar; Roger Janz; Harald H Sitte; Gonzalo E Torres
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

6.  RESP18 is involved in the cytotoxicity of dopaminergic neurotoxins in MN9D cells.

Authors:  Yufang Huang; Jing Xu; Min Liang; Xiaoqi Hong; Haiyun Suo; Jie Liu; Mei Yu; Fang Huang
Journal:  Neurotox Res       Date:  2013-01-15       Impact factor: 3.911

7.  Amperometric measurements of catecholamine release from single vesicles in MN9D cells.

Authors:  Yan Dong; Michael L Heien; Marc M Maxson; Andrew G Ewing
Journal:  J Neurochem       Date:  2008-12       Impact factor: 5.372

8.  Complexity of dopamine metabolism.

Authors:  Johannes Meiser; Daniel Weindl; Karsten Hiller
Journal:  Cell Commun Signal       Date:  2013-05-17       Impact factor: 5.712

9.  Stable expression of the human dopamine transporter in N27 cells as an in vitro model for dopamine cell trafficking and metabolism.

Authors:  B S Cagle; M L Sturgeon; J B O'Brien; J C Wilkinson; R A Cornell; D L Roman; J A Doorn
Journal:  Toxicol In Vitro       Date:  2021-07-05       Impact factor: 3.685

10.  Effects of Simazine Exposure on Neuronal Development-Related Factors in MN9D Cells.

Authors:  Jia Yu; Xueting Li; Junwei Yang; Yanping Wu; Baixiang Li
Journal:  Med Sci Monit       Date:  2016-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.